Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Market is closed
News
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Call Transcript

Operator: Good afternoon. And welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, today’s program is being recorded.

Keep Reading →

February 27th, 2025 - News Transcripts

15 Stocks That Will Go to The Moon According to Analysts

15 Stocks That Will Go to The Moon According to Analysts

While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...

Keep Reading →

February 24th, 2025 - Hedge Funds News

15 Best Fast Growth Stocks To Buy Right Now

15 Best Fast Growth Stocks To Buy Right Now

In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market expectations of 2.7% and a deceleration from the 3.1% growth observed in the...

Keep Reading →

February 20th, 2025 - Hedge Funds News

12 Best Healthcare Stocks to Buy According to Analysts

12 Best Healthcare Stocks to Buy According to Analysts

McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.

Keep Reading →

February 7th, 2025 - Hedge Funds Industries News

Jim Cramer’s Lightning Rounds: 9 Stocks in Focus

Jim Cramer’s Lightning Rounds: 9 Stocks in Focus

Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock market's expectations for...

Keep Reading →

January 31st, 2025 - Hedge Funds News

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on SRPT.

Keep Reading →

January 20th, 2025 - News Stock Analysis

10 Best Gene Therapy Stocks to Buy Right Now

10 Best Gene Therapy Stocks to Buy Right Now

Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.

Keep Reading →

December 28th, 2024 - Hedge Funds Industries News

10 Best Performing Biotech Stocks in 2024

10 Best Performing Biotech Stocks in 2024

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.

Keep Reading →

December 23rd, 2024 - Hedge Funds News

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.

Keep Reading →

December 14th, 2024 - News Stock Analysis

12 High Growth Large Cap Stocks to Buy Now

12 High Growth Large Cap Stocks to Buy Now

BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.

Keep Reading →

November 14th, 2024 - Hedge Funds News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)